Home › Companies › RECURSION PHARMACEUTICALS INC. › 2024-2025
Compiled from SEC Form N-PX filings and RECURSION PHARMACEUTICALS INC.’s Form 8-K, filed 2025-06-18 (Item 5.07 on EDGAR). Page generated 02 October 2026.
Explore RECURSION PHARMACEUTICALS INC. in the interactive database Compare manager voting policies
These tallies are RECURSION PHARMACEUTICALS INC.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed 2025-06-18 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX. RECURSION PHARMACEUTICALS INC. reported 2 meetings in this season; each is tabulated separately below, with its own filing.
| Ballot item | For | Against | Abstain | Withheld | Broker non-votes | Outcome |
|---|---|---|---|---|---|---|
| Elect Director: Zachary Bogue, J.D. | 242,298,743 | -- | -- | 3,971,237 | 93,369,778 | Majority: yes |
| Elect Director: Zavain Dar | 203,315,209 | -- | -- | 42,954,771 | 93,369,778 | Majority: yes |
| Elect Director: Robert Hershberg, M.D. Ph.D. | 233,487,438 | -- | -- | 12,782,542 | 93,369,778 | Majority: yes |
| Proposal 2: The advisory resolution to approve executive compensation, as disclosed in the Proxy Statement, was approved, with the following votes cast: | 239,911,332 | 3,242,536 | 3,116,112 | -- | 93,369,778 | Majority: yes |
| Proposal 3: The appointment of PricewaterhouseCoopers LLP as independent registered public accounting firm for the year ending December 31, 2025 was ratified, with the following votes cast: | 334,613,329 | 1,968,162 | 3,058,267 | -- | -- | Majority: yes |
Source: RECURSION PHARMACEUTICALS INC., Form 8-K, filed with the SEC on 2025-06-18 — read the filing on EDGAR.
| Ballot item | For | Against | Abstain | Withheld | Broker non-votes | Outcome |
|---|---|---|---|---|---|---|
| Proposal 1: approved. | 250,943,702 | -- | 2,003,579 | 568,667 | 0 | Majority: yes |
Source: RECURSION PHARMACEUTICALS INC., Form 8-K, filed with the SEC on 2024-11-13 — read the filing on EDGAR.
Each item below shows how the 300 asset managers that disclosed a RECURSION PHARMACEUTICALS INC. vote in their SEC Form N-PX filings actually voted. Share totals are the shares those managers' funds voted, summed across every fund they report. These are reported items, not a count of the ballot: fund filings describe one ballot item in different words. Two descriptions are shown as one item only on evidence — the same text (or one cut short of the other), the same director nominee, or a match to the same row of RECURSION PHARMACEUTICALS INC.’s own Form 8-K tally — never because they merely read alike. A description that could not be joined that way is listed on its own, so one ballot item can appear more than once.
Meeting held 2025-06-18.
Combines 9 wordings of this item as funds reported it.
99% Majority: yes · of votes cast
RECURSION PHARMACEUTICALS INC.’s own tally for this item (“Proposal 2: The advisory resolution to approve executive compensation, as disclosed in the Proxy Statement, was approved, with the following votes cast:”): 239,911,332 for, 3,242,536 against, per its Form 8-K filed 2025-06-18 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 406,410,733 outstanding shares: 59% for, 0.8% against (60% of the company cast a for/against vote).
The 281 asset managers below cast 99.2% of the shares they voted on this item FOR (73,166,145 for, 559,859 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Kinnevik AB (publ) | 13,434,171 | 0 | 0 | 0 | For |
| Mubadala Investment Co PJSC | 12,985,927 | 0 | 0 | 0 | For |
| Novo Holdings A/S | 9,665,128 | 0 | 0 | 0 | For |
| Nikko Asset Management Co., Ltd. | 8,476,829 | 0 | 0 | 0 | For |
| Lingotto Investment Management LLP | 3,675,077 | 0 | 0 | 0 | For |
| BlackRock | 2,961,938 | 0 | 0 | 0 | For |
| State Street | 2,755,192 | 1,177 | 0 | 0 | For |
| Vanguard | 1,723,496 | 0 | 0 | 0 | For |
| Laurion Capital Management LP | 1,547,407 | 0 | 0 | 0 | For |
| Northern Trust | 1,415,253 | 0 | 0 | 0 | For |
| MIC Capital Management UK LLP | 1,388,889 | 0 | 0 | 0 | For |
| Irish Life Investment Managers Ltd. | 1,232,365 | 0 | 0 | 0 | For |
| ARK Investment Management LLC | 948,092 | 0 | 0 | 0 | For |
| Vestmark Advisory Solutions, Inc. | 675,884 | 0 | 0 | 0 | For |
| Liontrust Investment Partners LLP | 595,955 | 0 | 0 | 0 | For |
| Lazard | 583,734 | 0 | 0 | 0 | For |
| BAILLIE GIFFORD OVERSEAS LTD | 510,162 | 0 | 0 | 0 | For |
| CAPITAL FUND MANAGEMENT S.A. | 472,342 | 0 | 0 | 0 | For |
| Fidelity | 468,545 | 0 | 0 | 0 | For |
| Charles Schwab | 451,093 | 0 | 0 | 0 | For |
| Ensign Peak Advisors, Inc | 410,286 | 0 | 0 | 0 | For |
| UBS | 0 | 393,958 | 0 | 0 | Against |
| MELLON INVESTMENTS Corp | 381,990 | 0 | 0 | 0 | For |
| ROCKEFELLER FINANCIAL LLC | 378,511 | 0 | 0 | 0 | For |
| Equitable | 288,136 | 0 | 0 | 0 | For |
Showing the 25 largest of 281 asset managers. See all 281 in the interactive database.
Meeting held 2025-06-18.
Combines 2 wordings of this item as funds reported it.
99.4% Majority: yes · of votes cast
RECURSION PHARMACEUTICALS INC.’s own tally for this item (“Proposal 3: The appointment of PricewaterhouseCoopers LLP as independent registered public accounting firm for the year ending December 31, 2025 was ratified, with the following votes cast:”): 334,613,329 for, 1,968,162 against, per its Form 8-K filed 2025-06-18 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 406,410,733 outstanding shares: 82% for, 0.5% against (83% of the company cast a for/against vote).
The 56 asset managers below cast 99.9% of the shares they voted on this item FOR (5,515,519 for, 0 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 1,533,439 | 0 | 0 | 0 | For |
| BlackRock | 1,100,917 | 0 | 0 | 0 | For |
| State Street | 375,304 | 0 | 0 | 0 | For |
| Equitable | 288,136 | 0 | 0 | 0 | For |
| Fidelity | 261,523 | 0 | 0 | 0 | For |
| Lincoln Financial | 238,651 | 0 | 0 | 0 | For |
| Charles Schwab | 225,068 | 0 | 0 | 0 | For |
| ARK Venture Fund | 199,568 | 0 | 0 | 0 | For |
| WisdomTree | 149,993 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 128,445 | 0 | 0 | 0 | For |
| Northern Trust | 115,547 | 0 | 0 | 0 | For |
| WESMARK FUNDS | 111,200 | 0 | 0 | 0 | For |
| First Trust | 103,157 | 0 | 0 | 0 | For |
| Pacific Life | 78,245 | 0 | 0 | 0 | For |
| Investment Managers Series Trust II | 58,014 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 49,449 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 45,753 | 0 | 0 | 0 | For |
| Global X | 42,251 | 0 | 0 | 0 | For |
| DWS | 39,068 | 0 | 0 | 0 | For |
| SEI Exchange Traded Funds | 34,446 | 0 | 0 | 0 | For |
| SEI | 34,000 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 32,768 | 0 | 0 | 0 | For |
| Guggenheim | 30,789 | 0 | 0 | 0 | For |
| AMERICAN BEACON FUNDS | 28,434 | 0 | 0 | 0 | For |
| Direxion Shares ETF Trust | 27,917 | 0 | 0 | 0 | For |
Showing the 25 largest of 56 asset managers. See all 56 in the interactive database.
Meeting held 2024-11-12.
Combines 2 wordings of this item as funds reported it.
87% fund support · no official result
The 56 asset managers below cast 87% of the shares they voted on this item FOR (13,609,642 for, 2,001,388 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 9,030,158 | 0 | 0 | 0 | For |
| State Street | 3,864 | 1,684,228 | 0 | 0 | Against |
| BlackRock | 1,114,022 | 0 | 0 | 0 | For |
| Fidelity | 904,022 | 133,373 | 0 | 0 | For |
| TIAA | 333,538 | 0 | 0 | 0 | For |
| Equitable | 276,795 | 0 | 0 | 0 | For |
| Charles Schwab | 274,859 | 0 | 0 | 0 | For |
| Lincoln Financial | 57,708 | 161,900 | 0 | 0 | Against |
| Dimensional | 208,147 | 0 | 0 | 0 | For |
| Russell Investments | 170,223 | 0 | 0 | 0 | For |
| ARK Venture Fund | 125,321 | 0 | 0 | 0 | For |
| Northern Trust | 112,470 | 0 | 0 | 0 | For |
| Neuberger Berman | 111,595 | 0 | 0 | 0 | For |
| WESMARK FUNDS | 111,200 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 91,442 | 0 | 0 | 0 | For |
| Pacific Life | 87,521 | 0 | 0 | 0 | For |
| SEI | 55,151 | 0 | 0 | 0 | For |
| Brighthouse | 21,631 | 0 | 32,111 | 0 | Abstain |
| John Hancock | 47,927 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 46,258 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 43,512 | 0 | 0 | 0 | For |
| Global X | 43,317 | 0 | 0 | 0 | For |
| DWS | 38,347 | 0 | 0 | 0 | For |
| AMERICAN BEACON FUNDS | 34,085 | 0 | 0 | 0 | For |
| Guggenheim | 30,400 | 0 | 0 | 0 | For |
Showing the 25 largest of 56 asset managers. See all 56 in the interactive database.
Meeting held 2024-11-12.
Combines 2 wordings of this item as funds reported it.
100% fund support · no official result
The 56 asset managers below cast 100% of the shares they voted on this item FOR (15,643,141 for, 0 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 9,030,158 | 0 | 0 | 0 | For |
| State Street | 1,688,092 | 0 | 0 | 0 | For |
| BlackRock | 1,114,022 | 0 | 0 | 0 | For |
| Fidelity | 1,037,395 | 0 | 0 | 0 | For |
| TIAA | 333,538 | 0 | 0 | 0 | For |
| Equitable | 276,795 | 0 | 0 | 0 | For |
| Charles Schwab | 274,859 | 0 | 0 | 0 | For |
| Lincoln Financial | 219,608 | 0 | 0 | 0 | For |
| Dimensional | 208,147 | 0 | 0 | 0 | For |
| Russell Investments | 170,223 | 0 | 0 | 0 | For |
| ARK Venture Fund | 125,321 | 0 | 0 | 0 | For |
| Northern Trust | 112,470 | 0 | 0 | 0 | For |
| Neuberger Berman | 111,595 | 0 | 0 | 0 | For |
| WESMARK FUNDS | 111,200 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 91,442 | 0 | 0 | 0 | For |
| Pacific Life | 87,521 | 0 | 0 | 0 | For |
| SEI | 55,151 | 0 | 0 | 0 | For |
| Brighthouse | 53,742 | 0 | 0 | 0 | For |
| John Hancock | 47,927 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 46,258 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 43,512 | 0 | 0 | 0 | For |
| Global X | 43,317 | 0 | 0 | 0 | For |
| DWS | 38,347 | 0 | 0 | 0 | For |
| AMERICAN BEACON FUNDS | 34,085 | 0 | 0 | 0 | For |
| Guggenheim | 30,400 | 0 | 0 | 0 | For |
Showing the 25 largest of 56 asset managers. See all 56 in the interactive database.
Meeting held 2025-06-18.
Combines 7 wordings of this item as funds reported it.
95% Majority: yes · of votes cast
RECURSION PHARMACEUTICALS INC.’s own tally for this item (“Elect Director: Robert Hershberg, M.D. Ph.D.”): 233,487,438 for, 12,782,542 withheld, per its Form 8-K filed 2025-06-18 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 406,410,733 outstanding shares: 57% for, 3% withheld (61% of the company cast a for/withheld vote).
The 55 asset managers below cast 100% of the shares they voted on this item FOR (2,178,675 for, 0 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 489,488 | 0 | 1,043,951 | 0 | Abstain |
| BlackRock | 0 | 0 | 1,100,917 | 0 | Abstain |
| State Street | 375,282 | 0 | 22 | 0 | For |
| Equitable | 4,890 | 0 | 283,246 | 0 | Abstain |
| Fidelity | 152,370 | 0 | 109,153 | 0 | For |
| Lincoln Financial | 238,444 | 0 | 207 | 0 | For |
| Charles Schwab | 0 | 0 | 225,068 | 0 | Abstain |
| ARK Venture Fund | 199,568 | 0 | 0 | 0 | For |
| WisdomTree | 149,993 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 128,445 | 0 | 0 | 0 | For |
| Northern Trust | 0 | 0 | 115,547 | 0 | Abstain |
| WESMARK FUNDS | 111,200 | 0 | 0 | 0 | For |
| First Trust | 103,157 | 0 | 0 | 0 | For |
| Pacific Life | 0 | 0 | 78,245 | 0 | Abstain |
| Bridge Builder Trust | 0 | 0 | 49,449 | 0 | Abstain |
| QUANTITATIVE MASTER SERIES LLC | 0 | 0 | 45,753 | 0 | Abstain |
| Global X | 0 | 0 | 42,251 | 0 | Abstain |
| DWS | 0 | 0 | 39,068 | 0 | Abstain |
| SEI Exchange Traded Funds | 0 | 0 | 34,446 | 0 | Abstain |
| SEI | 0 | 0 | 34,000 | 0 | Abstain |
| Columbia Threadneedle | 32,768 | 0 | 0 | 0 | For |
| Guggenheim | 30,789 | 0 | 0 | 0 | For |
| AMERICAN BEACON FUNDS | 28,434 | 0 | 0 | 0 | For |
| Direxion Shares ETF Trust | 27,917 | 0 | 0 | 0 | For |
| Calvert | 26,030 | 0 | 0 | 0 | For |
Showing the 25 largest of 55 asset managers. See all 55 in the interactive database.
Meeting held 2025-06-18.
Combines 6 wordings of this item as funds reported it.
98% Majority: yes · of votes cast
RECURSION PHARMACEUTICALS INC.’s own tally for this item (“Elect Director: Zachary Bogue, J.D.”): 242,298,743 for, 3,971,237 withheld, per its Form 8-K filed 2025-06-18 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 406,410,733 outstanding shares: 60% for, 1.0% withheld (61% of the company cast a for/withheld vote).
The 55 asset managers below cast 100% of the shares they voted on this item FOR (5,196,752 for, 0 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 1,533,439 | 0 | 0 | 0 | For |
| BlackRock | 1,100,917 | 0 | 0 | 0 | For |
| State Street | 375,304 | 0 | 0 | 0 | For |
| Equitable | 44,922 | 0 | 243,214 | 0 | Abstain |
| Fidelity | 261,523 | 0 | 0 | 0 | For |
| Lincoln Financial | 238,444 | 0 | 207 | 0 | For |
| Charles Schwab | 225,068 | 0 | 0 | 0 | For |
| ARK Venture Fund | 199,568 | 0 | 0 | 0 | For |
| WisdomTree | 149,993 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 128,445 | 0 | 0 | 0 | For |
| Northern Trust | 115,547 | 0 | 0 | 0 | For |
| WESMARK FUNDS | 111,200 | 0 | 0 | 0 | For |
| First Trust | 103,157 | 0 | 0 | 0 | For |
| Pacific Life | 78,245 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 49,449 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 45,753 | 0 | 0 | 0 | For |
| Global X | 42,251 | 0 | 0 | 0 | For |
| DWS | 39,068 | 0 | 0 | 0 | For |
| SEI Exchange Traded Funds | 34,446 | 0 | 0 | 0 | For |
| SEI | 34,000 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 32,768 | 0 | 0 | 0 | For |
| Guggenheim | 30,789 | 0 | 0 | 0 | For |
| AMERICAN BEACON FUNDS | 28,434 | 0 | 0 | 0 | For |
| Direxion Shares ETF Trust | 27,917 | 0 | 0 | 0 | For |
| Calvert | 26,030 | 0 | 0 | 0 | For |
Showing the 25 largest of 55 asset managers. See all 55 in the interactive database.
Meeting held 2025-06-18.
Combines 6 wordings of this item as funds reported it.
83% Majority: yes · of votes cast
RECURSION PHARMACEUTICALS INC.’s own tally for this item (“Elect Director: Zavain Dar”): 203,315,209 for, 42,954,771 withheld, per its Form 8-K filed 2025-06-18 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 406,410,733 outstanding shares: 50.1% for, 11% withheld (61% of the company cast a for/withheld vote).
The 55 asset managers below cast 100% of the shares they voted on this item FOR (3,431,734 for, 0 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 1,533,418 | 0 | 21 | 0 | For |
| BlackRock | 1,100,917 | 0 | 0 | 0 | For |
| State Street | 1,061 | 0 | 374,243 | 0 | Abstain |
| Equitable | 44,922 | 0 | 243,214 | 0 | Abstain |
| Fidelity | 261,523 | 0 | 0 | 0 | For |
| Lincoln Financial | 0 | 0 | 238,651 | 0 | Abstain |
| Charles Schwab | 0 | 0 | 225,068 | 0 | Abstain |
| ARK Venture Fund | 199,568 | 0 | 0 | 0 | For |
| WisdomTree | 0 | 0 | 149,993 | 0 | Abstain |
| AIG/SunAmerica | 0 | 0 | 128,445 | 0 | Abstain |
| Northern Trust | 0 | 0 | 115,547 | 0 | Abstain |
| WESMARK FUNDS | 0 | 0 | 111,200 | 0 | Abstain |
| First Trust | 0 | 0 | 103,157 | 0 | Abstain |
| Pacific Life | 78,245 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 49,449 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 45,753 | 0 | 0 | 0 | For |
| Global X | 0 | 0 | 42,251 | 0 | Abstain |
| DWS | 0 | 0 | 39,068 | 0 | Abstain |
| SEI Exchange Traded Funds | 0 | 0 | 34,446 | 0 | Abstain |
| SEI | 0 | 0 | 34,000 | 0 | Abstain |
| Columbia Threadneedle | 32,768 | 0 | 0 | 0 | For |
| Guggenheim | 0 | 0 | 30,789 | 0 | Abstain |
| AMERICAN BEACON FUNDS | 28,434 | 0 | 0 | 0 | For |
| Direxion Shares ETF Trust | 0 | 0 | 27,917 | 0 | Abstain |
| Calvert | 0 | 0 | 26,030 | 0 | Abstain |
Showing the 25 largest of 55 asset managers. See all 55 in the interactive database.
Meeting held 2025-06-18.
99% Majority: yes · of votes cast
RECURSION PHARMACEUTICALS INC.’s own tally for this item (“Proposal 2: The advisory resolution to approve executive compensation, as disclosed in the Proxy Statement, was approved, with the following votes cast:”): 239,911,332 for, 3,242,536 against, per its Form 8-K filed 2025-06-18 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 406,410,733 outstanding shares: 59% for, 0.8% against (60% of the company cast a for/against vote).
The 8 asset managers below cast 99.9% of the shares they voted on this item FOR (14,806,861 for, 3,161 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| SOFTBANK GROUP CORP. | 14,667,491 | 0 | 0 | 0 | For |
| JPMorgan | 129,653 | 0 | 0 | 0 | For |
| TD Waterhouse Canada Inc. | 3,431 | 0 | 0 | 0 | For |
| Desjardins Global Asset Management Inc. | 0 | 3,161 | 0 | 0 | Against |
| Coyle Financial Counsel LLC | 2,618 | 0 | 0 | 0 | For |
| SIERRA SUMMIT ADVISORS LLC | 2,618 | 0 | 0 | 0 | For |
| Empirical Financial Services, LLC d.b.a. Empirical Wealth Ma | 1,050 | 0 | 0 | 0 | For |
| Investment Partners Asset Management, Inc. | 0 | 0 | 1,000 | 0 | Abstain |
Ranked by the number of RECURSION PHARMACEUTICALS INC. shares each manager voted on the most widely held ballot item of the 2024-2025 meeting, shown as a share of the 406,410,733 shares outstanding at the time of that meeting.
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | Kinnevik AB (publ) | 3.31% |
| 2 | Mubadala Investment Co PJSC | 3.20% |
| 3 | Novo Holdings A/S | 2.38% |
| 4 | Nikko Asset Management Co., Ltd. | 2.09% |
| 5 | Lingotto Investment Management LLP | 0.90% |
| 6 | BlackRock | 0.73% |
| 7 | State Street | 0.68% |
| 8 | Vanguard | 0.42% |
| 9 | Laurion Capital Management LP | 0.38% |
| 10 | Northern Trust | 0.35% |
Positions disclosed to the SEC on Schedules 13D and 13G, Form 13F and the company’s own proxy statement (DEF 14A).
| Holder | % outstanding | Disclosure |
|---|---|---|
| ARK Investment Management LLC | 9.18% | 13G |
| Vanguard Group | 7.94% | 13F |
| BAILLIE GIFFORD & CO | 5.85% | 13G |
| BlackRock | 5.78% | 13F |
| Zachary Bogue | 3.35% | DEF14A |
| State Street | 3.22% | 13F |
| RA Capital Management, L.P. | 1.90% | 13G |
| Blake Borgeson | 1.76% | DEF14A |
| FMR (Fidelity) | 1.68% | 13F |
| Geode Capital | 1.59% | 13F |
Percentages above are of 406,410,733 shares outstanding, as reported by RECURSION PHARMACEUTICALS INC. on its Form 10-Q dated 2025-03-31 (see the filing on EDGAR). This is the count contemporaneous with the 2024-2025 meeting, so the percentages are the ones that were true then, not ones restated against today’s share count.
Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered investment companies and institutional managers disclose how they voted every proxy, and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from RECURSION PHARMACEUTICALS INC.’s 10-Q dated 2025-03-31. This page is a static snapshot rebuilt weekly on 02 October 2026; a live search always shows the current data.
At RECURSION PHARMACEUTICALS INC.'s 2 shareholder meetings in the 2024-2025 proxy season (held 2024-11-12 and 2025-06-18), 300 asset managers reported how they voted in their SEC Form N-PX filings, covering 1,505 separate fund positions. Their filings are grouped here into 8 reported items; because filers word the same ballot item differently, that can be more than the number of items on the ballot. On the most widely held item of the season, voted at the meeting held 2025-06-18 — Advisory vote to approve executive compensation as disclosed in the 2025 Proxy Statement. — FOR was 99% of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side), which is more than half. Whether the item was approved is for the filing to say; that statement has not been read for this item. Source: RECURSION PHARMACEUTICALS INC.'s Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on 2025-06-18.
RECURSION PHARMACEUTICALS INC. proxy season coverage: 2023-2024 · 2024-2025 (this page) · 2025-2026.